18 F-FET PET for Detection of Recurrent Disease in Gliomas: Tips and Tricks for Interpretation
Fluorine 18–fluoroethyltyrosine (FET) PET is a powerful tool in distinguishing posttreatment changes from tumor recurrence, with interpretation of findings based on semiquantitative assessment.
Authors
- Ian G. Law (ORCID: https://orcid.org/0000-0001-9644-7496)
- Javier E. Villanueva-Meyer (ORCID: https://orcid.org/0000-0002-5910-0757)
- Timothy L. Chen (ORCID: https://orcid.org/0009-0007-0932-5492)
- Thomas A. Hope (ORCID: https://orcid.org/0000-0002-2228-5823)
- Andrew Mark Scott (ORCID: https://orcid.org/0000-0002-6656-295X)
- Wolfgang Weber (ORCID: https://orcid.org/0000-0002-7854-4345)
- Robert R. Flavell (ORCID: https://orcid.org/0000-0002-8694-1199)
Institutions
- University of California, San Francisco (US)
- La Trobe University (AU)
- Austin Hospital (AU)
- Copenhagen University Hospital (DK)
- Austin Health (AU)
- Olivia Newton-John Cancer Research Institute (AU)
- Technical University of Munich (DE)
Publication Details
- Journal
- Radiographics
- Published
- 2026-11-05
- DOI
- https://doi.org/10.1148/rg.260105
- Primary Topic
- Medical Imaging Techniques and Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.00